Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Common Stock Subscribed But Not Issued [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 314 $ 5 $ 112,975 $ (104,617) $ (577) $ 8,100
Beginning balance, shares at Dec. 31, 2020 314,418,812 11,413        
Exercise of stock options     9     9
Exercise of stock options, shares 82,885,000          
Release of shares under stock grants          
Release of shares under stock grants, shares 6,877,000          
Conversion of promissory notes to stock, shares           12,542,126
Distributions to non-controlling interests       (183) $ (183)
Stock-based compensation     1,600     1,600
Net income       11,713 186 11,899
Issuance of subscribed shares   $ (5) 5    
Issuance of subscribed shares, shares 11,413 (11,413)        
Exercise of warrants $ 1   60     61
Exercise of warrants, shares 698,812          
Conversion of debentures payable to equity $ 5   1,352     1,357
Coversion of debentures payable to equity, shares 4,610,645,000          
Conversion of promissory notes to equity $ 7   2,253     2,260
Conversion of promissory notes to equity, shares 6,937,400,000          
Stock issued to settle obligations     53     53
Stock issued to settle obligations, shares 71,691,000          
Equity issuance costs     (387)     (387)
Ending balance, value at Jun. 30, 2021 $ 327 117,920 (92,904) (574) 24,769
Ending balance, shares at Jun. 30, 2021 326,838,535        
Beginning balance, value at Dec. 31, 2020 $ 314 $ 5 112,975 (104,617) (577) 8,100
Beginning balance, shares at Dec. 31, 2020 314,418,812 11,413        
Ending balance, value at Dec. 31, 2021 $ 334 134,920 (97,392) (1,563) 36,299
Ending balance, shares at Dec. 31, 2021 334,030,348        
Exercise of stock options   3     $ 3
Exercise of stock options, shares 10,000         39,899,423
Cashless exercise of stock options          
Cashless exercise of stock options, shares 200,000          
Cashless exercise of warrants          
Cashless exercise of warrants, shares 234,961          
Release of shares under stock grants          
Release of shares under stock grants, shares 356,938,000          
Shares issued as purchase consideration - business acquisition $ 3 1,497     1,500
Shares issued as purchase consideration - business acquisition, shares 2,343,750,000          
Purchase of minority interests in certain of the Company’s subsidiaries   (2,165)   165 (2,000)
Stock issued as payment of fees $ 1   273     274
Stock issued as payment of fees, shares 375,000,000          
Conversion of promissory notes to stock $ 1   399     $ 400
Conversion of promissory notes to stock, shares 1,142,858,000         12,542,126
Distributions to non-controlling interests         (184) $ (184)
Stock-based compensation   5,024     5,024
Net income       6,011 126 6,137
Ending balance, value at Jun. 30, 2022 $ 339 $ 139,951 $ (91,381) $ (1,456) $ 47,453
Ending balance, shares at Jun. 30, 2022 338,693,855